^SAMPLE = GSM552528!Sample_title = Malignant mesothelioma, Y-MESO-21!Sample_geo_accession = GSM552528!Sample_status = Public on Jun 15 2010!Sample_submission_date = Jun 08 2010!Sample_last_update_date = Jun 09 2010!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = Pooled normal genomic DNA, Male!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = sample type: Normal human genomic DNA purchased from Promega!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = DNA was prepared by standard techniques.!Sample_label_ch1 = Cy3!Sample_label_protocol_ch1 = The samples were labeled using the Agilent Genomic DNA Labeling Kit PLUS according to manufacture's instructions. DNA was fragmented using restriction enzymes. Random hexamers were used to prim an Exo-Klenow fragment DNA polymerase reaction incorporating CyDye labeled dUTP.!Sample_source_name_ch2 = Y-MESO-21 genomic DNA!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = cell line: Human malignant pleural mesothelioma cell line, Y-MESO-21!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = DNA was prepared by standard techniques.!Sample_label_ch2 = Cy5!Sample_label_protocol_ch2 = The samples were labeled using the Agilent Genomic DNA Labeling Kit PLUS according to manufacture's instructions. DNA was fragmented using restriction enzymes. Random hexamers were used to prim an Exo-Klenow fragment DNA polymerase reaction incorporating CyDye labeled dUTP.!Sample_hyb_protocol = The samples were hybridized for 40 hours using Agilent Oligo aCGH Hybridization Kit according to the manufacture's instructions.!Sample_scan_protocol = Arrays were scanned on an Agilent carousel scanner following manufacture's instructions. Agilent Feature Extraction software was used to extract the data.!Sample_description = Malignant mesotehlioma cell line!Sample_data_processing = Agilent Feature Extraction software!Sample_platform_id = GPL9128!Sample_contact_name = Hideki,,Murakami!Sample_contact_email = hmurakami@aichi-cc.jp!Sample_contact_phone = +81-52-764-2993!Sample_contact_fax = +81-52-764-2993!Sample_contact_department = Division of Molecular Oncology!Sample_contact_institute = Aichi Cancer Center Institute!Sample_contact_address = 1-1 Kanokoden Chukusa-ku!Sample_contact_city = Nagoya!Sample_contact_state = Aichi!Sample_contact_zip/postal_code = 464-8681!Sample_contact_country = Japan!Sample_supplementary_file = NONE!Sample_series_id = GSE22237!Sample_data_row_count = 236385#ID_REF = #VALUE = normalized log10 ratio Cy5/Cy3#CH1_SIG_MEAN = Cy3 Mean signal#CH1_BKD_MEAN = Cy3 background Mean signal#CH2_SIG_MEAN = Cy5 Mean signal#CH2_BKD_MEAN = Cy5 background Mean signal!sample_table_beginID_REF	VALUE	CH1_SIG_MEAN	CH1_BKD_MEAN	CH2_SIG_MEAN	CH2_BKD_MEANA_14_P100000	-1.12E-02	3.37E+02	4.34E+01	3.78E+02	5.71E+01A_14_P100001	8.11E-02	3.65E+02	4.74E+01	4.73E+02	6.40E+01A_14_P100002	3.36E-02	4.89E+02	4.49E+01	5.81E+02	5.92E+01A_14_P100003	-6.06E-02	2.47E+02	4.24E+01	2.52E+02	6.23E+01A_14_P100005	-1.54E-02	4.72E+02	4.54E+01	5.11E+02	6.37E+01A_14_P100006	-1.83E-03	2.06E+02	4.60E+01	2.29E+02	6.17E+01A_14_P100007	-2.37E-01	3.22E+02	4.47E+01	2.35E+02	5.97E+01A_14_P100008	3.50E-02	3.55E+02	4.56E+01	4.25E+02	6.07E+01A_14_P100009	3.34E-02	4.15E+02	4.84E+01	4.95E+02	6.50E+01A_14_P100010	1.33E-01	3.48E+02	4.39E+01	4.86E+02	6.21E+01A_14_P100011	7.52E-02	4.57E+02	4.33E+01	5.95E+02	6.24E+01A_14_P100012	2.97E-02	3.50E+02	4.65E+01	4.19E+02	5.81E+01A_14_P100013	6.99E-02	5.32E+02	4.53E+01	6.63E+02	6.09E+01A_14_P100014	1.84E-01	1.33E+02	4.68E+01	1.95E+02	6.13E+01A_14_P100015	1.54E-01	3.51E+02	4.16E+01	5.11E+02	6.17E+01A_14_P100016	-4.68E-02	2.96E+02	4.75E+01	3.06E+02	6.29E+01A_14_P100017	3.67E-02	2.51E+02	4.55E+01	3.05E+02	5.80E+01A_14_P100018	8.32E-02	5.02E+02	4.69E+01	6.61E+02	5.96E+01A_14_P100019	-1.92E-01	6.33E+02	4.59E+01	4.75E+02	6.00E+01A_14_P100020	-3.62E-02	2.75E+02	4.45E+01	2.87E+02	6.28E+01!sample_table_end